Title: Compositions and Methods for Inhibiting Expression of Factor VII Gene
Patent Number: 8,334,273
Filed: Dec. 19, 2010
Lead Inventor: Antonin de Fougerolles, Alnylam Pharmaceuticals
“The invention relates to a double-stranded ribonucleic acid for inhibiting the expression of the factor VII gene,” the patent's abstract states.
Title: Lactic Acid Bacteria-Derived Double-Stranded RNA